Clinical Trial Update: A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination [Phase 2]

View source ↗

Summary

Phase II study evaluating conversion surgery after intraperitoneal paclitaxel with XELOX in advanced gastric cancer with peritoneal dissemination; status not kn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• Paclitaxel (intraperitoneal) (paclitaxel)
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Advanced Gastric Cancer, Peritoneal Carcinomatosis | Phase 2 | Status: UNKNOWN